LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Intellijoint Surgical Launches in Japan
Large Joints and Extremities

Intellijoint Surgical Launches in Japan

July 2, 2021 1 min read Premium comments

Advertisement

Secondary#intellijointsurgical

Intellijoint Surgical, based in Kitchener, Ontario, Canada, is celebrating its official launch in Japan, with Dr. Toshiaki Okura becoming the first surgeon in the country to use Intellijoint HIP®, a surgeon-controlled navigation system that offers real-time measurements for optimal implant alignment and positioning.

“We’ve been eagerly anticipating this launch in Japan and it’s finally here. We are so proud that our Intellijoint HIP navigation technology will benefit the great people of Japan,” says Armen Bakirtzian, company co-founder and CEO. “Joint pain impacts people all over the world and it’s our mission to provide every surgeon with the best tools to optimize patient outcomes.”

With five hip replacement surgeries in Japan and counting, Intellijoint received rave reviews from surgeons. Intellijoint and its local distribution partner, Japan Medical Dynamic Marketing, are excited by this promising start.

According to Intellijoint, Japanese surgeons are saying that it is easy to see the angle numbers for inclination and anteversion because the screen is bigger than other systems they have used. These surgeons say that they appreciate that Intellijoint HIP is larger and easier to read while they are in the middle of cases. The Japanese surgeons are also saying that Intellijoint’s camera reaction is better and more responsive than others they have used—and it allows for easy registration.

Armen Bakirtzian told OTW, “Our one-year goal is simple: we want to show surgeons and patients in Japan the many benefits of Intellijoint’s technology. And doing that will enable our continued growth. Japan is a very important market for us and this next year is about getting our product in as many surgeon’s hands, so they experience the Intellijoint difference firsthand.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy